Market Watch: Bioventus Inc (BVS)’s Noteworthy Gain, Closing at 7.90

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Bioventus Inc’s stock clocked out at $7.90, up 4.50% from its previous closing price of $7.56. In other words, the price has increased by $4.50 from its previous closing price. On the day, 1.0 million shares were traded. BVS stock price reached its highest trading level at $7.97 during the session, while it also had its lowest trading level at $7.51.

Ratios:

To gain a deeper understanding of BVS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.94. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 2.62 whereas as Long-Term Debt/Eq ratio is at 2.34.

On August 09, 2023, Craig Hallum Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $4 to $6.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 21 ’24 when Singleton Mark Leonard sold 9,219 shares for $5.57 per share. The transaction valued at 51,350 led to the insider holds 84,895 shares of the business.

D’Adamio Anthony sold 5,904 shares of BVS for $32,885 on Jun 21 ’24. The SVP & General Counsel now owns 95,576 shares after completing the transaction at $5.57 per share. On Jun 21 ’24, another insider, CHURCH KATRINA J, who serves as the SVP & Chief Compliance Officer of the company, sold 2,559 shares for $5.57 each. As a result, the insider received 14,254 and left with 41,199 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BVS now has a Market Capitalization of 514976512 and an Enterprise Value of 926670528. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.96 while its Price-to-Book (P/B) ratio in mrq is 3.41. Its current Enterprise Value per Revenue stands at 1.726 whereas that against EBITDA is 18.913.

Stock Price History:

Over the past 52 weeks, BVS has reached a high of $8.36, while it has fallen to a 52-week low of $2.82. The 50-Day Moving Average of the stock is 19.24%, while the 200-Day Moving Average is calculated to be 50.83%.

Shares Statistics:

It appears that BVS traded 507.59K shares on average per day over the past three months and 593380 shares per day over the past ten days. A total of 63.27M shares are outstanding, with a floating share count of 40.19M. Insiders hold about 38.34% of the company’s shares, while institutions hold 34.63% stake in the company. Shares short for BVS as of 1722384000 were 1729514 with a Short Ratio of 3.41, compared to 1719532800 on 624625. Therefore, it implies a Short% of Shares Outstanding of 1729514 and a Short% of Float of 3.8599998.

Most Popular